Access Resources
2281 - 2290 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,17End Page: 19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792796.54034.5fCitation Count: 0
-
RESTRICTEDTitle: Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technologyJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 9Start Page: 875End Page: 891Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17434440.2021.1962286Citation Count: 8
- Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating2021RESTRICTEDTitle: Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical RatingJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2962End Page: 2963Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28776Citation Count: 3
-
RESTRICTEDTitle: Neurodegenerative disorder diagnosis using support vector machine and Naive bayes algorithmsJournal Name: 2021 Third International Conference on Inventive Research in Computing Applications (ICIRCA)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/icirca51532.2021.9545021Citation Count: 0
-
RESTRICTEDTitle: New Questions About a Mysterious Neurologic Cluster in CanadaJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,20End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2bCitation Count: 0
- Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone2021RESTRICTEDTitle: Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicaponeJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 9Start Page: 1019End Page: 1033Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1968298Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14737175.2021.1968298?needAccess=trueCitation Count: 17
-
OPENTitle: Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancerJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-25467-wBest OA location URL: https://www.nature.com/articles/s41467-021-25467-w.pdfCitation Count: 8
-
RESTRICTEDTitle: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2286End Page: 2286Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092286Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823Citation Count: 10
-
RESTRICTEDTitle: A comparative and comprehensive study of prediction of Parkinson’s diseaseJournal Name: Indonesian Journal of Electrical Engineering and Computer SciencePublisher: Institute of Advanced Engineering and ScienceVol: 23Issue #: 3Start Page: 1748End Page: 1748Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.11591/ijeecs.v23.i3.pp1748-1760Best OA location URL: http://ijeecs.iaescore.com/index.php/IJEECS/article/download/25890/15468Citation Count: 0
-
RESTRICTEDTitle: A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 90End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.034Citation Count: 5